DICER1 and cancer: The therapeutic modulation of Dicer1 and its associated proteins via molecules acting as activators, such as enoxacin, or inhibitors like CIB-3b, presents promising new approaches for cancer treatment [41,42], providing innovative ways to interfere with cancer progression and highlighting the importance of miRNA biogenesis in cancer progression.